We’re thrilled to share some exciting news with you! ARC CPTT is honoured to announce that Dr Danilo Tagle, Director of the Office for Special Initiatives at the National Center for Advancing Translational Sciences (NCATS), NIH, will be visiting us for a special event that promises to be both enlightening and inspiring. Dr. Tagle’s remarkable expertise and leadership in advancing translational and clinical tools have positioned him as a leader in the field.

🗓️ Save the Date:

Date: Friday, 10 May 2024

Time: 2pm to 3pm

Venue: ESJ King Theatre, Level 3, West Wing Medical Building (181)

🎙️ Public Lecture Topic:

“Advancing Translational and Clinical Tools for Improved Predictive Risk Assessments and Precision Medicine”

Join us for what promises to be an enlightening and captivating lecture, where Dr. Tagle will present the use of cutting-edge tools such as microphysiological systems (organs-on-chips) to better predict drug efficacy and toxicity before clinical testing in people.

For any inquiries, please don’t hesitate to reach out to our ARC CPTT Centre manager, Dr. Delphine Denoyer, at ddenoyer@unimelb.edu.au .

Don’t miss out on this exceptional opportunity to gain insights from one of the leading figures in translational sciences. We can’t wait to welcome you and share in the excitement of Dr. Tagle’s visit!

See you there!

Thank you for your contribution to the ARC Centre for Personalised Therapeutics Technologies (CPTT) in 2023. We look forward to working with you further in the final year of the Centre. Wishing you and your family a wonderful holiday season and and best wishes for the new year!

As part of our Annual Training Forum, the ARC Centre for Personalised Therapeutics Technologies is hosting a 3-hr symposium on “Advancing Innovation: From Research to Real-World Impact”.

Date and Time: 1.30pm- 4:30pm Friday 3 November 2023

About the Event: The event aims to shed light on the process of translating scientific discoveries into clinical applications, bridging the gap between academic research and real-world applications, and introducing attendees to the world of venture capital.

Our speaker line-up includes:

• Dr Ebony Fietz, Drug Development Manager, Currus Biologics
• Dr Katherine Jackman, Investment Manager, Brandon Capital
• Dr Mark Devlin, CEO, Aculeus Therapeutics
• Ms Maria Pelipas, Research Startup Accelerator Manager – Air Program (TRAM)
• Dr Patrick Schriek, Senior Scientist, CSL

Target Audience: Graduate researchers and early-career researchers with an interest in translating research to real-world applications.

The event will be held in person and online. If you are interested to be part of this event, please contact the Centre Manager at therapeutics-technologies@unimelb.edu.au.

We look forward to seeing you at this event!

CSIRO, in collaboration with government, research and industry partners has released a report which marks an important milestone in Australia’s journey towards more efficient medical product development. The University of Melbourne was among the sponsors of this important study. CPTT director, Prof Alastair Stewart contributed to the development of this report, and is proud to share the results of this collaboration with CSIRO.

The report, Non-animal models: A strategy for maturing Australia’s medical product development capabilities, assesses the potential of emerging non-animal models to complement or replace traditional animal models over the next 15 years.

Highlighting Australia’s strengths and aligning them with global needs, the report emphasises four key opportunities:

1.Complex in vitro models for drug discovery

2.Organ-specific models for preclinical development

3.Personalized models for trial participant and clinical treatment selection

4.Onshore production of model components

Ten recommendations have been designed to enable these opportunities and strategically advance Australia’s national non-animal model ecosystem.    Embrace the future of medical research and development. Read the full report.